Timing of Starting and Stopping GLP-1 Treatment Around Tummy Tuck Surgery and Its Effects on Weight and Complications

Postoperative outcomes among patients using GLP-1 receptor agonists were assessed under three different management protocols.

• Three protocols were compared: at least 2-week preoperative cessation and delayed resumption, preoperative cessation with early postoperative resumption, and short preoperative cessation with no postoperative resumption.
• The increasing use of GLP-1 receptor agonists for weight loss is leading to more patients seeking abdominoplasty.
• Evidence-based guidelines for managing these medications during surgery are currently lacking.

Simplified